72.13
0.08 (0.11%)
0.08 (0.11%)
Upgrade to Real-Time
Afterhours (Closed)
Best deals to access real time data! |
|
Big Cap Pro
Monthly Subscription
for only
|
|
Small Cap Basic
Monthly Subscription
for only
|
|
Real-Time Alerts for Volume Breakouts, Highs and Lows for NYSE, NASDAQ, Amex, OTC Markets and OTCBB
Monthly Subscription
for only
|
|
VAT not included
|
| Company Name | Stock Ticker Symbol | Market | Type |
|---|---|---|---|
| Eidos Therapeutics Inc | EIDX | NASDAQ | Common Stock |
| Price Change | Change Percent | Stock Price | Last Traded  |
|
|---|---|---|---|---|
| 0.08 | 0.11% | 72.13 | 19:26:57 |
| Close Price | Low Price | High Price | Open Price | Previous Close |
|---|---|---|---|---|
| 72.13 | 71.25 | 73.15 | 71.26 | 72.05 |
| Bid Price | Ask Price | Spread | News | |
|---|---|---|---|---|
| 71.00 | 72.43 | 1.43 | 2 | 1 |
| Stock Trades | Traded Volume | VWAP | Dollar Volume | Average Volume | 52 Week Range |
|---|---|---|---|---|---|
| 1,851 | 90,687 | $ 72.33 | $ 6,559,167 | 328,844 | 28.39 - 76.94 |
| Last Trade Time | Type | Quantity | Stock Price | Currency |
|---|---|---|---|---|
| 17:20:30 | 25 | $ 72.13 | USD |
Eidos Therapeutics Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| $ 2.78B | 38.59M | 11.03M | $ 26.69M | $ - | -1.04 | - |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | $ - | 0.00% | - | - |
Eidos Therapeutics News
Loading Messages....
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical EIDX Price Data
| Period † | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 73.37 | 76.00 | 70.57 | 73.46 | 304,937 | -1.24 | -1.69% |
| 1 Month | 50.77 | 76.94 | 50.15 | 73.11 | 439,796 | 21.36 | 42.07% |
| 3 Months | 41.40 | 76.94 | 38.9601 | 66.69 | 191,195 | 30.73 | 74.23% |
| 6 Months | 50.96 | 76.94 | 38.24 | 59.33 | 136,996 | 21.17 | 41.54% |
| 1 Year | 42.20 | 76.94 | 28.39 | 55.52 | 139,383 | 29.93 | 70.92% |
| 3 Years | 20.00 | 76.94 | 8.89 | 36.11 | 154,868 | 52.13 | 260.65% |
| 5 Years | 20.00 | 76.94 | 8.89 | 36.11 | 154,868 | 52.13 | 260.65% |
Eidos Therapeutics Description
| Eidos Therapeutics Inc is a clinical stage biopharmaceutical company focused on addressing the large and growing unmet need in diseases caused by transthyretin, or TTR, amyloidosis, or ATTR. TTR is a protein that occurs naturally in the form of a tetramer and performs multiple beneficial roles, including the transport of essential hormones and vitamins. |
